Angiotensin-converting enzyme inhibitors from Salvia elegans Vahl.
Nat Prod Res
; 35(23): 5344-5349, 2021 Dec.
Article
en En
| MEDLINE
| ID: mdl-32347111
Phytochemical research of the acetate and methanol extracts of the aerial parts (flowers, leaves and stems) of Salvia elegans allowed to obtain seventeen known compounds (1-17): three of them (4, 5, 14), had already been described for this species, while the others (1-3, 6-13, 15-17) are described for the first time for S. elegans. All isolated compounds were characterized using spectroscopic techniques and mass spectrometry and were evaluated in the Angiotensin I-converting enzyme (ACE) inhibition model, where the phenolic compounds (13, 14 and 15) had the same inhibitory effect as lisinopril at 0.02 mg/mL. The terpenes showed a moderate inhibitory capacity at a concentration of 0.2 mg/mL.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inhibidores de la Enzima Convertidora de Angiotensina
/
Salvia
Idioma:
En
Revista:
Nat Prod Res
Año:
2021
Tipo del documento:
Article
Pais de publicación:
Reino Unido